Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 0 | 0 | 1,000 | 0 | 0 |
| Cost of Goods | N/A | N/A | 100 | N/A | N/A |
| Gross Profit | N/A | N/A | 900 | 0 | N/A |
| Operating Expenses | 7,146 | 8,623 | 17,735 | 11,619 | 6,977 |
| Operating Income | -7,146 | -8,623 | -16,735 | -11,619 | -6,977 |
| Other Income | 124 | 209 | -9 | 4,784 | -108 |
| Pre-tax Income | -7,022 | -8,414 | -16,744 | -6,835 | -7,085 |
| Net Income Continuous | -7,022 | -8,414 | -16,744 | -6,598 | -7,085 |
| Net Income | $-7,022 | $-8,414 | $-16,744 | $-6,598 | $-7,085 |
| EPS Basic Total Ops | -0.34 | -0.41 | -1.05 | -0.43 | -0.45 |
| EPS Basic Continuous Ops | -0.34 | -0.41 | -1.05 | -0.43 | -0.45 |
| EPS Diluted Total Ops | -0.34 | -0.41 | -1.05 | -0.43 | -0.45 |
| EPS Diluted Continuous Ops | -0.34 | -0.41 | -1.05 | -0.43 | -0.45 |
| EBITDA(a) | $-7,146 | $-8,623 | $-6,735 | $-11,619 | $-6,977 |